Companies / Eidos Therapeutics, Inc.
Eidos Therapeutics, Inc.
EIDXCIK 1731831
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 13, 2021 | Sinha Uma Executive | Sell Open-market sale | Common Stock | $615.4K | -5K -1.57% | 308,825 | medium |
| Jan 13, 2021 | Sinha Uma Executive | Sell Open-market sale | Common Stock | $250.7K | -2K -0.65% | 306,825 | medium |
| Jan 12, 2021 | Valle Franco Executive | Sell Open-market sale | Common Stock | $219.2K | -2K -100.00% | 0 | medium |
| Jan 11, 2021 | Valle Franco Executive | Sell Open-market sale | Common Stock | $188.4K | -2K -100.00% | 0 | medium |
| Jan 13, 2021 | Sinha Uma Executive | Sell Open-market sale | Common Stock | $185.0K | -1K -0.48% | 313,759 | medium |
| Jan 13, 2021 | Sinha Uma Executive | Sell Open-market sale | Common Stock | $84.3K | -696 -0.22% | 315,829 | low |
| Jan 13, 2021 | Sinha Uma Executive | Sell Open-market sale | Common Stock | $69.9K | -572 -0.18% | 315,257 | low |
| Jan 13, 2021 | Sinha Uma Executive | Sell Open-market sale | Common Stock | $37.9K | -300 -0.10% | 306,525 | low |